1Albert C. Clinical aspects of gastric cancer, in: Rustgi AK, eds.Cas:rointestinal cancer: biology, diagnosis and therapy.Philadelphia: Lippincott Raven 1995:197-216. 被引量：1
2Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ.Epidemiology of gastroenterologic cancer in Henan Province,China. World J Gastroenterol 2003; 9:2400-2403. 被引量：1
3Maehara Y, Kakeji Y, Masuda T, Sakoguchi T, lmamura M,Ohgaki K, Taniguchi K, Sakurai M, Futatsugi M, Kimura Y,Nakamura T, Tokunaga E, Oki E, Ushiro S, Watanabe M, Oda S, Tanaka S, Baba H. Treatment of gastric cancer: current state and future prospect. Fukuoka Igaku Zasshi 2003; 94:285-295. 被引量：1
4De Paoli A, Buonadonna A, Boz G, Lombardi D, lnnocente R,Tumolo S, Tosolini G, Rossi C, Trovo MG, Frustaci S. Combined modality treatment for locally advanced gastric cancer.Suppl Tumori 2003; 2:S58-S62. 被引量：1
5Macdonald JS. Chemotherapy Jn the management of gastric cancer. J Chin Oncol 2003; 21: 276s-279s. 被引量：1
7Mahajan DK, London SN. Mifepristone (RU486): a review.Fertil Steril 1997; 68:967-976. 被引量：1
8Liang Y, Hou M, Kallab AM, Barrett JT, El Etreby F, Schoenlein PV. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbetal. Int J Oncol 2003; 23:369-380. 被引量：1
9El Etreby MF, Liang Y, Wrenn RW, Schoenlein PV. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1998; 51:149-168. 被引量：1
10El Etreby MF, Liang Y. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice. Breast Cancer Res Treat 1998; 49:109-117. 被引量：1
